High-concentration vials mean small measurement mistakes can give you 510 your intended dose
The following individual and combined search terms were used: GLP-1, Semaglutide and Liraglutide, molecular mechanism, lipid metabolism, insulin metabolism, glucose homeostasis, energy expenditure obesity treatment, type 2 diabetes mellitus, side effects, clinical trials, treatment option, fatty liver disease, hypertension, neurodegenerative diseases, cardiovascular diseases, therapeutic options. Only articles published in the last 10 years are included, although older pivotal studies were added
A second search of both databases for GLP-1 and CK, myalgias, muscle pain, or muscle atrophy was undertaken and also did not yield any reports
Target 0.7 to 1.0 grams of protein per pound of goal body weight daily
The key difference is that semaglutide users at the 2.4 mg dose report higher rates and longer duration of constipation compared to tirzepatide users, even at the highest 15 mg dose
elevate your head if reflux is an issue
